Conclusion
The novel nomogram developed in the current study for predicting survival of pediatric patients with histologically confirmed brainstem gliomas is the first to incorporate risk stratification. Therefore, combining nomogram and risk stratification system is a convenient tool to help clinicians identify high-risk patients and to perform targeted adjuvant treatment.